Jay Mei at BIIS 2018 (Endpoints/PharmCube)

Ex-Cel­gene ex­ec steers his biotech start­up to Hong Kong IPO as po­ten­tial can­cer drug launch looms

Jay Mei re­mem­bers the ex­act date he first met BeiGene CEO John Oyler.

It was May 14, 2016, and Mei — then an ex­ec­u­tive di­rec­tor of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.